Naor Nir's most recent trade in Axogen Inc. was a trade of 39,132 Common Stock done at an average price of $15.2 . Disclosure was reported to the exchange on Jan. 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Axogen Inc. | Nir Naor | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.22 per share. | 06 Jan 2025 | 39,132 | 260,868 (0%) | 0% | 15.2 | 595,589 | Common Stock |
Brainstorm Cell Therapeuti... | Nir Naor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 30,666 | 31,465 (0%) | 0% | 0 | Common Stock | |
Axogen Inc. | Naor Nir | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 300,000 | 300,000 (0%) | 0% | - | Common Stock | |
Brainstorm Cell Therapeuti... | Nir Naor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 11,999 | 11,999 (0%) | 0% | 0 | Common Stock |